TrialFrontiers in immunology2025

Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma.

Robert B Rebhun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.